From the Blood Journals

From the Blood Journals

Research from the Blood family of journals: Blood and Blood Advances

WIB_icon

Assessing the Updated Vienna Prediction Model for Unprovoked VTE: Does It Hold Up?

The Vienna Prediction Model was established to identify patients with unprovoked venous thromboembolism (VTE) who have a low risk of recurrence, with the aim...
WIB_icon

Understanding Familial Risk for Hodgkin Lymphoma

Hodgkin lymphoma (HL) represents approximately 1 percent of all de novo neoplasms worldwide annually, with more than 65,000 new cases diagnosed globally each year....
WIB_icon

Novel Combination of ISS and EMC92 Gene Classifier Leads to Better Risk Stratification in...

Patients with multiple myeloma have variable survival rates and require reliable prognostic and predictive scoring systems. Currently, the available clinical and biologic risk markers...
WIB_icon

Study Finds No Increased Risk of Transmission of CLL Through Blood Transfusions

An analysis of from Denmark and Sweden has shown that chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis (MBL) does not appear to be...
WIB_icon

Iron Supplementation for Women with Iron Deficiency: Less May Be More

Iron supplements can replete iron stores and increase hemoglobin levels in individuals with an iron deficiency, but it can come with a price in...
WIB_icon

Frontline Brentuximab Vedotin Leads to High Response Rate for Older Hodgkin Lymphoma Patients

Older patients with Hodgkin lymphoma (HL) tend to have worse outcomes than younger patients when treated with conventional chemotherapy regimens, likely due to a...
WIB_icon

Effectiveness of Treatment with VR-CAP Versus R-CHOP for Patients with Non-GCB DLBCL

Clinical outcomes differ considerably between the germinal center B-cell-like (GCB) and non-GCB subtypes of diffuse large B-cell lymphoma (DLBCL), with overall survival inferior in...
WIB_icon

Examining the Efficacy of Granulocyte Transfusion Therapy in Neutropenic Patients with Infection

Granulocyte transfusion therapy was an approach to bacterial and fungal infections related to severe neutropenia for more than 50 years; however, due to questionable...
WIB_icon

A New Topical Treatment for Cutaneous T-Cell Lymphoma

The investigational topical drug resiquimod was safe and effective in clearing treated and untreated skin lesions in patients with early-stage cutaneous T-cell lymphoma (CTCL),...
WIB_icon

A Closer Look at Cancer-Associated Venous Limb Gangrene

Warfarin-induced venous limb gangrene (VLG) in patients with cancer with deep-vein thrombosis (DVT) is an uncommon, poorly understood complication of anticoagulant therapy. While warfarin...
Advertisement

Current Issue

August 2020 Volume 6, Issue 10

This issue looks at the rapid expansion of telemedicine, explores access to leukemia treatment in Brazil, and more.

Block title